| 1. | Salzman EW, et al. Management of heparin therapy; a controlled prospective trial. N Engl J Med 1975; 292;1046-50. |
| 2. | Glazier RL, Crowell EB. Randomized prospective trial of continuous versus intermittent heparin therapy. JAMA 1976; 12; 1365-67. |
| 3. | Chenella FC, et al. Improved method for estimating initial heparin infusion rates. Am J Hosp Pharm 1979; 36;782-84. |
| 4. | Greenlaw CW, Henrietta GC, Stolley SN. Standardized heparin dosage schedule using pharmakokinetic principles. Am J Hosp Pharm 1979; 36;920-23. |
| 5. | Wilson JR, Lampman J. Heparin therapy: a randomized prospective study. Am Heart J 1979;155-8. |
| 6. | Estes, JW. Clinical Pharmacokinetics of Heparin. Clin Pharm 1980 5:204-220. |
| 7. | Wilson JE, Bynum LJ, Parkey RW, Heparin therapy in venous thromboembolism; JAMA 1981; 70; 808-16. |
| 8. | Self TH, et al. Concurrent initiation of heparin and warfarin therapy. Am Heart J. 1981; 102;470-71. |
| 9. | Hattersley PG, et al. Adjusting heparin infusion rates from the initial response to activated coagulation time. DICP 1983;17:632-634. |
| 10. | Saya Frank, et al. Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol. Am J Hosp Pharm 1985; 42:1965-1969. |
| 11. | Carter BL. LA. Therapy of acute thromboembolism with heparin and warfarin. Clin Pharm 1991; 10; 503-15. |
| 12. | Macleod CM, et al. Comparison of two methods of continuous intravenous heparin therapy. Hosp Pharm 1985; 20;649-54. |
| 13. | Hull RD, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal vein thrombosis. NEJM 1986;18:1109-14. |
| 14. | Cipolle RJ, Rodvold KA. "Heparin", in Evans W, Schentag J, Jusko J (eds): Applied Pharmacokinetics. San Francisco. Applied Therapeutics, 1986; pp 908-943. |
| 15. | Rivey MP, Peterson JP. Pharmacy-managed, weight-based heparin protocol. AJHP 1993; 50:pp 279-84. |
| 16. | Brill-Edwards P, et al. Establishing a therapeutic range for heparin therapy. Ann Intern Med 1993; 119:104-109. |
| 17. | Raschke RA, et al. The weight-based heparin nomogram compared with a standard care nomogram: a randomized controlled trial Ann Intern Med 1993; 119:874-81 |
| 18. | Kershaw B, et al. Computer-assisted dosing of heparin: management with a pharmacy-based anticoagulation service. Arch Intern Med 1994;154:10005-1011. |
| 19. | Campbell NR, et al. Aging and heparin-related bleeding. Arch Intern Med 1996; 156:857-60. |
| 20. | Schlicht JR, et al. Reevaluation of a weight-based heparin dosing nomogram: is institution specific modification necessary? Ann Pharmacother 1997; 31:1454-9. |
| 21. | White RH, et al. Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on stead-state intravenous heparin requirements. Arch Intern Med 1997;157:2468-2472. |
| 22. | Volles DF, et al. Establishing an institution-specific therapeutic range for heparin. AJHP 1998;55:2002-6. |
| 23. | Braunwald E, et al. Diagnosing and managing unstable angina, Quick reference quide for clinicians. US Dept of HHS, PHS, AHCPR, NHLBI. 1994, pp 6-7. |
See also:
Introduction
Monitoring parameters
Precautions
Pharmacokinetic formulas
|